A study to compare the study medicine (GDC-0810) to another treatment (fulvestrant) in patients with breast cancer

A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy

Cancer
Breast Cancer

Results
Download

Study results

LPS GO29689 HydranGea Final Results July 2020 English (PDF, 0.2 MB)

LPS GO29689 HydranGea Final Results July 2020 German (PDF, 0.2 MB)

LPS GO29689 HydranGea Final Results July 2020 Korean (PDF, 0.3 MB)

LPS GO29689 HydranGea Final Results July 2020 Spain Spanish (PDF, 0.2 MB)

LPS GO29689 HydranGea Final Tesults July 2020 USA Spanish (PDF, 0.2 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study to compare the study medicine (GDC-0810) to another treatment (fulvestrant) in patients with breast cancer

Study results

LPS GO29689 HydranGea Final Results July 2020 English (PDF, 0.2 MB)

LPS GO29689 HydranGea Final Results July 2020 German (PDF, 0.2 MB)

LPS GO29689 HydranGea Final Results July 2020 Korean (PDF, 0.3 MB)

LPS GO29689 HydranGea Final Results July 2020 Spain Spanish (PDF, 0.2 MB)

LPS GO29689 HydranGea Final Tesults July 2020 USA Spanish (PDF, 0.2 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A study to compare the study medicine (GDC-0810) to another treatment (fulvestrant) in patients with breast cancer

For the latest version of this information please go to www.forpatients.roche.com